INTRODUCTION
Somatostatin is an ubiquitous peptide distributed in the central, peripheral and autonomous nervous system, in the D-cells of the gastrointestinal tract, in the pancreas, and in other peripheral organs 1-4. It is possible that the peptide exerts its function in several ways: as a paracrine secretion, as a true hormone, and as a neurotransmitter [1] [2] [3] [4] Denmark. gastrointestinal peptides (gastrin, VIP, pancreatic polypeptide, secretin, motilin, insulin, glucagon, growth hormone and thyreotropine)1'3'4. Animal experiments and occasional studies in humans have shown that somatostatin reduces bile secretion after a short infusion time1 '4-7. In man the primary mode of action is on the bile acid-dependent canalicular bile flow, and to some extent on the ductular secretion 
RESULTS
Somatostatin infusion reduced the daily bile loss in all seven patients from a median of 473 ml to 140 ml (p 0.01, Figure 1 ). The median relative reduction in the daily loss ofbile was 41% (p 0.01). The reduction in bile secretion was seen from thefirst hour ofinfusion and the effect seemed to increase during the infusion period to about one third of the initial volume in the twentyfourth hour of infusion ( Table 1 ). The reduction in bile secretion was uncorrelated with the dosage infused per kg body weight (Figure 1 ).
There were no significant changes in the concentrations of the measured bile electrolytes but as the secreted bile volume was markedly reduced, hence the daily loss of electrolytes was significantly reduced, too. The most important effect concerned the loss of sodium and chloride, as both were reduced with more than 2 mmol/h corresponding to a median reduction in the daily loss of about 50 mmol (Table 1 ). There was also a significant reduction in the molar loss of cholesterol and triglycerid ( Table 1 ).
The significant increase in the concentration of bile acids was mainly due to an increase of glycochenodeoxycholic acid (p=0.04) giving a significant increase in the glycine conjugated acids (p 0.01, Table 2 ). The total hourly molar loss of bile acids showed a marginally significant reduction (p=0.051, Table 3 ). The 
